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In situ tissue regeneration can be defined as the implantation of tissue-specific
biomaterials (by itself or in combination with cells and/or biomolecules) at the tissue
defect, taking advantage of the surrounding microenvironment as a natural bioreactor.
Up to now, the structures used were based on particles or gels. However, with
the technological progress, the materials’ manipulation and processing has become
possible, mimicking the damaged tissue directly at the defect site. This paper presents a
comprehensive review of current and advanced in situ strategies for tissue regeneration.
Recent advances to put in practice the in situ regeneration concept have been mainly
focused on bioinks and bioprinting techniques rather than the combination of different
technologies to make the real in situ regeneration. The limitation of conventional
approaches (e.g., stem cell recruitment) and their poor ability to mimic native tissue
are discussed. Moreover, the way of advanced strategies such as 3D/4D bioprinting and
hybrid approaches may contribute to overcome the limitations of conventional strategies
are highlighted. Finally, the future trends and main research challenges of in situ enabling
approaches are discussed considering in vitro and in vivo evidence.
Keywords: in situ approaches, tissue regeneration, bioprinting, in situ biomaterials, computer/non-computer
assisted approaches
INTRODUCTION
Every year, millions of people around the world suffer from tissue damage, either due to disease,
trauma, or simply aging (Badylak and Nerem, 2010; O’Brien, 2011). Although autografts and
allografts are considered gold standard procedures for organ transplantation, many limitations
remain, such as a donor shortage, donor site morbidity, and adverse immune responses (Atala,
2004; Dias et al., 2016). The need for alternative approaches has led to the foundation of tissue
engineering (TE), an exciting field of research that over the last 25 years has used materials in the
presence or absence of cells and biochemical factors to restore, maintain, or improve biological
tissues (Langer and Vacanti, 1993). During this period, scientists have recognized that tissue
reconstruction is an extremely complex task that cannot be performed by simply bringing cells and
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materials together (Hoffman et al., 2019). The exciting path
of TE, however, allowed the scientific community to gain a
deeper understanding of cell and stem cell biology, uncovering
the importance of the properties of the extracellular matrix
(ECM) in directing cell behavior. Cells are intrinsically sensitive
to local signals from the macro- to the nanoscale, including
both chemical (e.g., a specific molecule recognition) and physical
(e.g., topographical pattern) signals (Crowder et al., 2016). In
addition, they can be stimulated by the mechanical environment
(tissue-like stiffness) (Chowdhury et al., 2010) or when exposed
to shear fluid rates close to that of the target biological system
(Blaeser et al., 2016).
As our understanding of how the physical and chemical
properties of the ECM direct stem cell fate and tissue formation
has evolved, we have observed a simultaneous development of
advanced biomaterials with the capacity to recapitulate such
properties locally at the tissue interface (Stuart et al., 2010;
Dhowre et al., 2015). These smart materials can be dynamically
altered by chemistry, enzymes, light, and mechanics, among
others (Momeni et al., 2017; Miri et al., 2018).
To implant tissue-specific biomaterials alone or in
combination with cells and biomolecules at the site of the
tissue defect is a concept that has been defined as in situ tissue
regeneration. This approach takes advantage of the surrounding
biological microenvironment, directing the fate of cells to
regenerate new tissue without complicated prior in vitro cell
manipulation (Li et al., 2015). Several reviews can be found
in the literature describing what is currently known about
the mechanisms and strategies used to induce in situ cell
differentiation and tissue regeneration (Chen et al., 2011; Yang
et al., 2014; Talacua et al., 2015; Dhand et al., 2016; Murdock and
Stephen, 2017; Wissing et al., 2017).
A very important aim for in situ tissue regeneration strategy
is the development of technologies to manipulate and process
materials at the defect site, recreating the tissue’s size and
shape in the surgical room. This implies that the selection of
materials must meet new requirements, while the processing
technologies need to be more sophisticated to meet the demands
of portability, adaptability, and simplicity for use over a relatively
short period of time. Therefore, in situ approaches need state-
of-the-art customized processing technologies. The advances
in micro- and nano-fabrication technologies can provide the
platforms to engineer structures at high resolution with the
capacity to fully recreate in situ the complexity of a tissue defect
(Holzmond and Li, 2017; Bella et al., 2018; Hakimi et al., 2018;
Hudita et al., 2019).
Progress in areas such as cell culture automation, techniques
for cell sorting, and new material formulations for biofabrication,
have generated more efficient therapies for preclinical models
as well as to repair simple tissues in the laboratory. Although
self-sustaining solutions that facilitate full tissue integration and
homeostasis in a timely manner remain elusive, there has been
great progress in the development of technological strategies for
in situ tissue regeneration.
This review provides a perspective on the potential and
state of development of different in situ fabrication technologies
for multiple tissue regeneration, such as non-computer-based
approaches (in situ spraying and spinning, and in situ hydrogel-
based strategies) and computer-based approaches (in situ 3D/4D
bioprinting and in situ hybrid approaches). The next generation
of constructs should, ideally, not only mimic the organs or tissues’
architecture and properties but also consider the dynamics of
material and the cell-material interaction.
MATERIALS FOR IN SITU TISSUE
REGENERATION
Initially, in situ tissue regeneration was proposed mainly as a
strategy to avoid complicated and long-term in vitro cell isolation,
expansion, and maturation (Li et al., 2015). Additionally, this
approach overcomes the poor integration of in vitro new tissue
that commonly occurs after implantation (Smits et al., 2016).
Based on this, in situ tissue regeneration intends to promote
regeneration, taking advantage of the native microenvironment
of the injury site through the implantation of tissue-specific
biomaterials combined or not with biomolecules or cells
(Figure 1) (Li et al., 2015; Zhao et al., 2017). This approach is
a dynamic process in which cells recruited from host or delivered
by the scaffold must proliferate, self-assemble, and differentiate
before reaching a steady-state (Murdock and Stephen, 2017). The
in situ tissue regeneration takes advantage of native biochemical
and biophysical cues that, contrary to what happens in a
bioreactor, is a simple, scalable, and cost-effective methodology
(Murdock and Stephen, 2017).
Regardless of the in situ fabrication strategy used, biomaterials
have a key role in the regeneration process. Initially, in situ
regeneration approaches focused on cell recruitment to the
injury site through biomaterials and/or biological cues (Ko
et al., 2013; Lee et al., 2016). However, it is well known that a
non-target-specific scaffolding system lacks with the formation
functional tissue (Sengupta et al., 2014). Consequently, the best
approach to achieve an appropriate tissue regeneration comprises
the combination of scaffolds with cells or biomolecules that
mimic the injury target tissue/organ with immunomodulatory
properties (Lee et al., 2016; Smits et al., 2016). Natural
and synthetic materials are suitable for in situ regeneration
if they are biodegradable, have a minimal pro-inflammatory
response, have anti-inflammatory properties, and promote an
immunomodulatory response (Li et al., 2015; Murdock and
Stephen, 2017). Additionally, the physical properties, chemical
composition, and biological functions of the material must
modulate the cellular response (adhesion, proliferation, and
differentiation) as well as neo-tissue formation (Li et al.,
2015). Commonly, in situ biomaterials are categorized as
natural biomaterials, synthetic polymers, bioceramics, and ECM-
based materials (Li et al., 2015; Murdock and Stephen, 2017).
Natural biomaterials including polysaccharides (such as cellulose,
alginate, hyaluronic acid, starch, dextran, heparin, chitin, and
chitosan) and proteins (collagen, gelatin, and fibrin) have
been broadly used in in situ regeneration due to their ECM
similarity and recognition sites (Li et al., 2015; Lee et al., 2016).
Contrary to natural biomaterials, synthetic polymers present
good mechanical properties and can be manufactured easily with
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FIGURE 1 | In situ regeneration approaches. (a) Host stem cell recruitment- biostructures (particles, gel or decellularized ECM) recruit cells from the surrounding
environment; (b) In situ cell release – cells are released from the biostructure to the surrounding environment, commonly produced by electrospinning or bioprinting
strategies.
high precision (Li et al., 2015; Murdock and Stephen, 2017).
Commonly used synthetic polymers in situ are poly(L-lactic acid)
(PLLA), polyurethane (PU), poly(lactic-co-glycol acid) (PLGA),
and poly(caprolactone) (PCL), although the lack of functional
groups limits their cell affinity (Sengupta et al., 2014; Murdock
and Stephen, 2017). Bioceramics, of natural or synthetic origin,
are characterized by their biocompatibility, osteoconductivity,
corrosion resistance, and a hard and brittle structure (Pina et al.,
2017). Depending on the type of ceramics used, their interaction
with the host tissue can be categorized as bioinert or bioactive,
being the latest resorbable or non-resorbable (Vallet-Regí and
Ruiz-Hernández, 2011). Bioceramics can be used as powders,
granulates, or coatings, as well as being processed by additive
manufacturing techniques, making it possible for them to mimic
the architecture of bone ECM (Pina et al., 2017; Ma et al.,
2018). The fourth category, ECM-based materials, is one of the
most promising strategies due to the provided microenvironment
which mimics the native ECM (Li et al., 2015; Murdock and
Stephen, 2017). Despite ECM-based materials can be derived
from decellularized tissues that are similar to the native tissue
present as major limitation the donor shortage (Crapo et al., 2011;
Li et al., 2015). Nevertheless, due to the technological advances,
it is possible to create an ECM-based materials that mimic the
native tissues in terms of its architecture and biomechanical
properties and allows cells and biomolecules to be incorporated
(Li et al., 2015; Lee et al., 2016). It is important to highlight
that in most of the in situ approaches the use of biomaterials
is required (regardless of their shape or size), either being by
injection, surgery, or insertion into the defect. This will injure the
tissues or organs involved. Consequently, the use of minimally
invasive and time-effective approaches are required.
IN SITU ENABLING APPROACHES
The TE field has been growing exponentially during the past
few years, exploring the regeneration of several tissues (e.g.,
bone, skin, ligaments, tendons, and cartilage, among others)
using different approaches, namely top-down (cells are seeded
onto a prefabricated porous scaffold) or bottom-up (scaffolds are
fabricated combining modular units such as biomaterials, cells,
growth factors and biomolecules) (Dias et al., 2016). Presently,
the manipulation and processing of materials in the surgical room
takes materials science to a new level of sophistication, but at
the same time, highlights the need for easy application processes,
using technologies that could be as much as possible minimally
invasive, intuit and easy to manipulate for the surgeons, in order
to meet the time constrains of a clinical interventions, while
maintaining all the safety and sterility requirements needed.
This implies that the selection of materials must meet new
specifications, while the processing technologies need to be more
refined to meet the demands of portability, adaptability, and
simplicity for use over a relatively short period of time. The in situ
enabling technologies can be categorized in non-computer-
assisted (defect area is fulfill with non-defined deposition pattern)
or computer-assisted approaches (the defect is scanned and
deposition pattern defined accordingly).
Non-computer-Assisted Approaches
In situ Spinning and Spraying
In situ spinning and spraying are technologies that are now giving
their first steps toward a clinical application. Both approaches
intend to deposit fibers or particles into the defect area in
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a non-predefined strategy. Electrospinning has attracted great
interest in TE applications, by generating a diversity of nanoscale
fibers ranging from a few microns to less than 100 nm, made
of polymers, ceramics, or their composite scaffolds (Teo and
Ramakkrishna, 2006; Bhardwaj and Kundu, 2010; Shi et al., 2010;
Yang et al., 2018). In this technique, a polymer solution or melt is
added to a capillary and a small droplet (a Taylor cone) is formed
at the tip of the needle due to the extrusion of the precursor
spinning solution by the syringe pump in the presence of a high
electric voltage (Yarin et al., 2001). When the force between the
Taylor cone and the grounded collector under an electric field
is between 5 and 30 kV, it is able to overcome the solution
surface tension and a thin jet of the charged solution is accelerated
toward the target collector. If the solution is viscous enough to
stabilize the jet, the polymer solution is severely stretched and
the solvent evaporates to form ultrathin fibers that solidify and
deposit on the collector forming a non-woven mesh of fibers
(Greiner and Wendorff, 2007). However, when the collector
speed is increased, the fibers are rapidly taken up on the surface
of the collector tightly in a circumferential manner, resulting in
a high alignment. The final fiber diameter depends on various
parameters, including the applied voltage, the distance between
the tip and the collector, the solvent type, the solution feed
rate, the needle diameter, and the concentration of the polymer
solution (Matthews et al., 2002; Li and Xia, 2004; Inai et al., 2005;
Beachley and Wen, 2009; Liao et al., 2012).
These nano-sized fibers that mimic the native ECM have
been successfully electrospun, including biodegradable, non-
degradable, natural, and synthetic polymers such as collagen, silk,
gelatin, elastin, alginate, chitosan, PGA, PLLA, PLGA, and PCL
(Matthews et al., 2002; Huang et al., 2003; Min et al., 2004; Yang
et al., 2005; Buttafoco et al., 2006; Choi et al., 2008; Klossner
et al., 2008; Zeugolis et al., 2008; Hartman et al., 2009; Chen
et al., 2010; Liu et al., 2010; Zhou et al., 2010; Bonino et al.,
2011). Furthermore, the standard electrospinning setup can be
modified by replacing a single spinneret (nozzle) with a coaxial
nozzle to produce a single polymeric fiber composed of two
different simultaneously spun polymers, the structure of which
consist of a core-shell assembly (Loscertales et al., 2004; Wang
et al., 2006). Another approach is dual nozzle electrospinning
that enables the combination of a variety of polymers prepared
in independent solvents and electrospun at the same time
to make a hybrid scaffold. Additionally, the use of different
collectors allows control of the deposited fiber orientation
(Teo and Ramakkrishna, 2006). This further highlights the
versatility, reproducibility, scalability, and sustainability of the
electrospinning technique to produce different nanofibrous
structures with relevant potential for biomedical applications.
The incorporation of electrospinning in in situ biomedical
applications creates important challenges for how to re-design
conventional electrospinning devices, which use high voltages
and have limited portability, to become portable user-friendly
equipment that can be used in the “patient’s bed.” Therefore, great
efforts have been made to develop new portable electrospinning
devices for the purposes of wound dressing and regeneration
(Xu et al., 2015; Haik et al., 2017). An example is the
SkinCare (Figure 2), a portable wound care system developed by
Nanomedic Technologies Ltd (2019) in Israel. Yan et al. (2019)
reflects precisely the recent advances in portable electrospinning
technology for the in situ delivery of personalized wound
care and regenerative medicine. The currents involved in the
electrospinning process are in the order of nanoamperes. This
has inspired pioneering work on cell-spinning, where post-
electrospinning cells were shown to remain viable (Jayasinghe,
2013). Indeed, the implementation of spinning techniques,
together with the use of living cells in order to mimic the
complexity of the native tissues, might lead to the development
of functional biomaterials compatible with in situ TE and
subsequent successful clinical outcomes (Poncelet et al., 2012;
Chen et al., 2015).
As an alternative to in situ electrospinning, there are a
few studies that have reported a modified spinning technique,
namely, air flow-directed in situ electrospinning, which can
precisely control the deposition of polymeric fibers on a desired
site under the assistance of air flow (Jiang et al., 2014; Dong
et al., 2015; Lv et al., 2016). For example, Lv et al. (2016)
applied this technology to precisely deposit medical glue based
on octyl-2-cyanoacrylate (NOCA) ultrathin fibers onto dura
defects in goat brains to improve its sealing capability, to avoid
tissue adhesion, and to save time required for conventional
dura suture. In another work, the airflow assisted in situ
precision e-spinning was compared to the traditional spraying
method in the delivery of NOCA adhesive fibers by using a
model of liver injury in rats. Compared with spraying, in situ
precision e-spinning improved operational performance and
safety by precisely depositing a sufficiently small amount of
cyanoacrylate fibers onto a wound, in addition to producing
a rapid and complete hemostatic effect (e.g., minor hepatocyte
injury, moderate inflammation, and a significant ability for liver
regeneration) (Dong et al., 2015).
Electrospraying (ES) or electrohydrodynamic atomization
consists of a jetting methodology that relies on a potential
difference between two electrodes for accelerating a column of
liquid (Jaworek, 2007). The basis set up of ES is quite similar
to that used in the electrospinning technique; briefly consists
of a high voltage supply, a syringe pump, a syringe with a
metallic needle and a collector. In ES, when the electrical field
is applied the liquid jet is broken into fine liquid droplets with
similar charge promoting their dispersion (Jaworek, 2007). The
electric charge creates an electrostatic force inside the droplet
which is able to overcome its surface tension (Boda et al.,
2018). Subsequently, this excess of charge will be dissipated
and smaller charged droplets on the micro to nanoscale will be
ejected toward the collector (Jaworek and Sobczyk, 2008). These
electrosprayed droplets are commonly unstable and evaporate,
generating micro- and nanoparticulates (Bock et al., 2012).
The temperature and humidity affect the vaporization of the
solvent from the droplets generated during ES. Generally, the
particles are collected in ethanol or a water-ethanol mixture
or other water-based systems, since most of the polymers are
insoluble in water (Boda et al., 2018). Consequently, organic
solvents with high vapor pressure or a low surface tension are the
most suitable for ES (Jaworek and Sobczyk, 2008). Commonly, it
is easier to electrospray high molecular weight (Mw) polymers
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FIGURE 2 | (a) Handheld electrospinning device marketed by Nanomedic Technologies Ltd. Israel, (b) electrospun fiber deposition, (c) clinical case report, treatment
of second degree burn, modified from Nanomedic Technologies Ltd (2019).
at low solute concentrations in organic solvents than low Mw
polymers (Boda et al., 2018).
Several types of natural polymers, such as chitosan
(Songsurang et al., 2011), alginate (Park et al., 2012), cellulose
(Huang et al., 2012), or collagen (Nagarajan et al., 2014), as well
as synthetic PLGA (Nath et al., 2013), PCL (Hwang et al., 2008),
and polystyrene (PS) (Zheng et al., 2006) have been successfully
electrosprayed to generate nano/micro-particulate systems.
One of the potential applications of electrospraying is
bioelectrospraying (BES), which consists of the in situ delivery
of living cells (Braghirolli et al., 2013) or encapsulated cells
(Minglin et al., 2013) for TE and regenerative medicine (TERM)
applications (Jayasinghe, 2011). The use of bioelectrospraying
to process cell suspensions into 3D architectures for generating
functional tissue constructs has shown promising results in the
past few years (Jayasinghe, 2011).
Rabbit bone marrow stromal cells (BMSCs) subjected to
electrospraying with 6 mL/h of flow rate of and voltage of 7.5–
15 kV did not show deleterious effects on their morphology,
proliferation, or multilineage differentiation potential (Sambit
et al., 2010). Human deciduous tooth pulp MSCs exposed
between 15 and 60 min to 15 kV voltage, with a 0.46 mL/h
flow rate, did not present a significant decrease in cell viability,
proliferation, plasticity, or immunophenotypic profile, although
some DNA damage was observed after 30 min of BES, which
could be self-repaired after 5 h of culture (Braghirolli et al., 2013).
Abeyewickreme et al. (2009) described that bioelectrosprayed
mouse embryonic stem cells (ESCs) did not show alterations in
their pluripotency.
Pancreatic islets encapsulated in an alginate shell-matrigel
core configuration were processed by coaxial ES and were
able to maintain in vitro and in vivo viability and glucose
regulating functionality after transplantation in immune
competent mice (Minglin et al., 2013). In another study, alginate
microcapsules with core-shell structures plus rat pancreatic islets
were produced. When implanted in a type I diabetic mouse
model, it was shown that these hydrogel microcapsules with
core-shells improved islet cells encapsulation and conferred
immune protection (Zhao et al., 2014). A novel approach
combining microfluidic cell encapsulation with electrospinning
based membranes was developed using a layer-by-layer
process by alternating fiber electrospinning and cell spraying
(Weidenbacher et al., 2017). This system conferred a temporary
protection for the cells delivery (C2C12 cell line) to produce a
fibrous cell-laden hybrid biograft (Weidenbacher et al., 2017).
In situ thermoresponsive hydrogels composed of thermogelling
macromers (TGM) of Poly(N-isopropylacrylamide) (pNiPAAm)
sprayed with a high polyamidoamine (PAMAM) concentration
at low pressure with encapsulated cells were deposited using
single-stream, layer-by-layer, and dual-stream spraying as
coatings on interior intestinal porcine tissue, to create a
homogeneous therapeutic coating on the area to further treat
lesions triggered by inflammatory bowel disease (Figure 3)
(Pehlivaner et al., 2016).
Coaxial ES was used to encapsulate murine ESCs into alginate
microcapsules, and showed a higher pluripotency of the ESCs
according to their differentiation into cardiomyocytes and higher
expression of cardiomyocyte specific gene markers than the cells
cultured on 2D substrate or simple 3D alginate microbeads
(Zhao et al., 2014).
Human osteoarthritic chondrocytes and chondrons
(choncrocytes with their pericellular matrix) in fibrin gel
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FIGURE 3 | (I) Illustration of therapeutic delivery method of a cellular hydrogel
coating on intestinal tissue via a spray device. (II) SEM images of lateral cross
sections of hydrogels with TGM:PAMAM (1:1), scale bar: 500 mm. (III)
Fluorescence microscopy image of live(green)/dead(red)-treated sections of
10 wt% TGM and 10 wt% PAMAM hydrogels sprayed at 0.5 bar with
dual-stream method. (IV) Images of (A) porcine intestinal tissue and (B)
hydrogel formation on tissue after spraying for 1 min, scale bar: 1 cm
(Pehlivaner et al., 2016).
were airbrush sprayed using a commercial device (Baxter)
and cultured for 21 days to assess matrix production (De
Windt et al., 2015). To investigate the feasibility of the sprayed
cell-based fibrin glue scaffold, a full-thickness sized cartilage
defect was created arthroscopically in a cadaver model, and
the defects were filled with either arthroscopic airbrushing or
needle extrusion. Results showed that both chondrons and
chondrocytes can be distributed in a sprayed fibrin glue scaffold
without affect the cell viability and supporting the matrix
production (De Windt et al., 2015).
Platelet origin fibrin gel was used for spray painting in situ to
create a patch in a mouse model of myocardial infarction (Tang
et al., 2017). Platelet rich plasma and calcium-containing media
solution were sprayed in two different syringes with compressed
CO2 onto the heart of mice to produce a uniform patch,
which was found to promote cardiac repair and reduce cardiac
dysfunction after myocardial infarction (Tang et al., 2017).
Spray seeding is a technology that can be used for the delivery
of progenitor cells, Schwartz et al. (2017) have studied the impact
of spraying as a seeding strategy for repopulation of decellularized
small intestine onto decellularized scaffolds. In this work a
new spray device (3D Spray) has been used to seed intestinal
organoids to form epithelium on decellularized intestinal ECM
scaffolds as in vitro models (Schwartz et al., 2017).
Electrospray technology is one of the most promising
approaches in the TERM field, considering its wide availability,
easiness to set up and operate, reusability, and high production
rate. In situ electrospraying using cells with or without polymers –
bioelectrospraying – is of ultimate importance given the need to
create a fully 3D tissue, a concept that will easily be translated to
the clinic. However, compared to the in situ bioprinting, present
as the main limitations the random deposition and the poor
ability to fulfill a 3D defect.
Furthermore, in situ spinning and spraying allow for the
creation of structures either fibrilar or composed by agregated
micro/nano particles, which have typically small porosity and
are not ideal to build large, highly porous 3D constructs. These
are line-of-sight technologies that project the material and cells
onto the defect rather than building a precise shaped geometry
as in case of 3D printing. Therefore, it is then clear that skin
wound healing is the most important targeted application for
these technologies. The gold standard are portable devices that
are directly manipulated by the clinicians in a simple manner,
controlling the amount of materials/cell to be added, the most
adequate angle for projection or the moment when the defect is
fulfilled. This means that in most of the cases it is not necessary
to scan the damage area to have a defined computerized shape
of the defect. Nevertheless its existence can help to predict
the extension of the lesion and evaluate the exact amount of
material/cells to be used.
To find the adequate polymers to bring adequate structure
integrity, able to promote tissue regeneration and to guarantee
that the in situ process does not affect the surrounding cells and
tissue integrity are still challenges to overcome.
In situ Gelling
Hydrogels are 3D polymeric networks with a wide potential
in the field of TE due to their ability to support cell
proliferation, migration and differentiation, allow oxygen and
nutrient transport, and mimic native tissues. The importance
of these biomaterials in the field of TE when applied in situ
have been recently highlighted (Park and Park, 2018). These
networks might be composed of crosslinked natural polymers
(e.g., alginate, chitosan, gelatin, silk) or synthetic macromolecules
[e.g., PEG, polyvinyl alcohol (PVA)] (Marchesan et al., 2013; Lee
and Kim, 2018). These highly hydrated networks can be stabilized
via physical or chemical crosslink (Moura et al., 2013). Hydrogels
might also be biodegradable, responsive to specific stimuli (i.e.,
pH or temperature) (Toh and Loh, 2014; Dabiri and Damstetter,
2016; Ribeiro et al., 2018), and engineered to deliver therapeutic
compounds in a sustained and controlled released way, exhibiting
properties such as adhesiveness, elasticity, and biocompatibility
(Toh and Loh, 2014). These matrices are versatile and can be
adapted, making them useful for filling deep defects or those with
irregular contours. On the other hand, they can be easily loaded
with bioactive agents which can trigger regenerative processes
at multiple cellular levels (Agubata et al., 2016). However, the
success of hydrogel applications as a delivery system in TE will
largely depend on the biomimetic design and engineering, and
cell-material interactions involved in cell fate (Figure 4) (Toh and
Loh, 2014; Dabiri and Damstetter, 2016; Nie et al., 2016).
Recent findings underscore the need for the development and
implementation of novel in situ hydrogel driven therapies. The
most pioneered advances in in situ hydrogel technology have
contributed to a paradigm shift in wound healing applications.
One of the most notable examples is an injectable gelatin
microcryogel, which can load cells for enhanced cell delivery
and cell therapy for wound healing (Zeng et al., 2015).
In Le Thi et al. (2017) study, human adipose-derived stem
cells (hASCs) laden in gelatin microcryogels were used as
primed injectable 3D micro-niches for a new cell delivery
methodology for skin wound healing. The study showed an
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FIGURE 4 | (A) Injectable hydrogels for tissue engineering applications, adapted from Choi et al. (2015). (B) Representative immunofluorescent images of collagen
deposition, adapted from Deng et al. (2017). (C) In vitro data of sericin hydrogels injected subcutaneously, adapted from Wang et al. (2014).
improvement in wound bed recovery and a direct effect on the
wound basal layer resulting in enhanced healing. A different
gelatin hydrogel was prepared by double enzymatic crosslinks,
where horseradish peroxidase (HRP) and tyrosinase were used
as crosslinking agents in order to develop a novel in situ
tissue-adhesive system (Le Thi et al., 2017). A biodegradable
in situ thermosensitive hydrogel has been developed by Gong
et al. (2013) as a controlled drug delivery system composed
of a one-step solid dispersion method with curcumin and
PEG-PCL copolymer for cutaneous wound repair, and has
been shown to be successful. Moreover, injectable in situ
crosslinking chitosan-hyaluronic acid based hydrogels have
shown notable potential in abdominal tissue regeneration
(Deng et al., 2017). Other advances have been made in
spinal degenerative disease, for example an in situ injectable
chemically crosslinked hydrogel formed by a two-component
reaction of liquid silk fibroin with liquid polyurethane at
physiological temperature conditions which was shown to fulfill
an entire defect, reducing the danger of implant relocation and
the subsequent loss of disk height, minimizing the operative
trauma (Hu et al., 2017). Efforts were also made in cartilage
regeneration using an injectable hydrogel with transforming
growth factor (TGF)-β1, which was considered capable of
promoting chondrogenesis (Zhou et al., 2017). This study
suggests that the new hydrogel possesses advantages for clinical
application and should further be studied for its future use
in cartilage TE.
An N-isopropylacrylamide/gelatin microparticle composite
hydrogel used in bone TE enhanced the mineralization within the
bone defect, which significantly increased tissue infiltration and
osteoid formation, suggesting that the hydrogel system facilitates
bone ingrowth and integration (Vo et al., 2016). Another
nanohydroxyapatite/glycol chitosan/hyaluronic acid composite
hydrogel was also designed for bone TE (Huang et al., 2016).
The good attachment and spread of the cells incorporated
after 7 days of co-incubation highlighted the potential of the
hydrogel for bone TE applications. In addition, an injectable
hydrogel using chitin and poly(butylene succinate) loaded with
fibrin nanoparticles and magnesium-doped Bioglass has been
investigated by Vishnu Priya et al. (2016). The hydrogel induced
osteogenic differentiation by stimulating the expression of
alkaline phosphatase and osteocalcin, being a promising strategy
for regenerating irregular bone defects. Another advantage of
hydrogels is their use as carriers for bioactive compounds, thus
improving their delivery performance. Ophthalmic in situ gels
have been developed to prolong the precorneal contact time of
ocular drugs. For example, sodium alginate and hydroxypropyl
methyl cellulose have been used to develop a new in situ gel for
diclofenac ophthalmic delivery (Subimol et al., 2013). Pluronic F-
127, a triblock copolymer with a non-ionic nature, goes through
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in situ gelation due to temperature changes. In a work by
Pagliarussi et al. (2006) a formulation containing this polymer
was incorporated with clotrimazole-β-cyclodextrin complex to
develop a vaginal in situ gel. This formulation increased the
release time of the drug at the application site.
Cardiovascular are amongst the most important fields of
application for in situ crosslinked hydrogels (Li et al., 2014;
Radhakrishnan et al., 2014). Recently, several injectable hydrogels
have emerged as a potential candidates for cardiac tissue
regeneration due to improved patient compliance and facile
administration via minimal invasive mode that treats complex
infarction (Radhakrishnan et al., 2014). For instances, in a
work of Steele et al. (2019) a catheter−injectable hyaluronic
acid hydrogel is proposed utilizing a polymer–nanoparticle
crosslinking mechanism. Due to the notable shear−thinning
the hydrogel can be easily injected through a long, narrow,
physiologically−relevant catheter and needle with hydrogel
mechanics unchanged after delivery.
When comparing with other in situ approaches it is clear
that while hydrogels can reach the entire volume of complex
defects, they may lack in adequate mechanical properties to
be able to successfully fill large hard tissue defects. On the
other hand, careful design of the formulation should result in
relatively fast forming hydrogel structures to be compatible with
clinical application (Wang et al., 2014). Therefore the gelling
time is a crucial parameter to be taken into consideration
together with an ideal viscosity to allow for minimally invasive
application. Soft tissue applications are no doubt the most
important target of in situ hydrogel systems were there have
been the greatest advances. At the same time, hydrogels have
been gaining momentum with the development of computer-
aided bioprinting technologies, to create more precise, porous 3D
constructs, openning the range of applications and creating the
possibility for loading bioactive factors or cells during fabrication
in a spacially controlled manner (Hakimi et al., 2018; Albanna
et al., 2019). However, the use of prefabricated hydrogel scaffolds
brings complexity to the TE approach as compared to the
procedure of directly inject a gel in situ.
Computer-Assisted Approaches
3D in situ Bioprinting
Three-dimensional (3D) printing emerged from additive
manufacturing technology and has been mainly used to print
biodegradable cell-free scaffolds in the field of TE. This top-
down approach, in which cells are only seeded at the end of
the printing process, presents some drawbacks, such as the
inaccurate control over the distribution of cells, which results
in a lack of structures to generate an appropriate ECM and the
regeneration fails (Mandrycky et al., 2016). Consequently, 3D
bioprinting emerged as one of the most promising bottom-up
technologies for fabricating artificial tissues and organs (Murphy
and Atala, 2014; Mandrycky et al., 2016), mainly due to its
capacity to create complex structures, in a layer-by-layer fashion,
with precise control over the deposition and positioning of
biomaterials, growth factors, living cells, biochemical, and
other functional components (Murphy and Atala, 2014; Seol
et al., 2014). Traditionally, the bioprinting process is based on
three individual and dependent phases. The first comprises
medical imaging [computer tomography (CT) or magnetic
resonance imaging (MRI)], which combined with computer-
aided design/manufacturing (CAD/CAM) software, enables a
3D CAD model of a defect or an organ from the patient to be
produced (Murphy and Atala, 2014; Seol et al., 2014; Bishop et al.,
2017). From that, it is possible to create a code for the printer
to generate a structure with an anatomical shape layer-by-layer
(Seol et al., 2014; Mandrycky et al., 2016). The second phase
corresponds to the printing and involves the selection of a
bioprinting technique as well as the biomaterials for bioinks and
scaffolds. The final properties of the structure will be affected
by the selected techniques and materials. The last phase occurs
when the structure is obtained and it can be: (i) maturated
in a bioreactor before in vivo application, (ii) implanted as it
is, or (iii) used as an in vitro model (Mandrycky et al., 2016;
Bishop et al., 2017). Although all the phases are crucial in the
bioprinting process, the printing stage is the most complex as
it is crucial to obtain structures with the desired properties.
Building human tissues by 3D bioprinting has received huge
attention in the TE field due to its process flexibility and
versatility. However, the need to implant the structure after
production has generated several issues related to the integration
with surrounding tissues, namely, (i) the difficulties to obtain
a perfect fit for the geometry of the defect, (ii) the need for
surgical debridement before scaffold implantation, and (iii) the
contamination risk (Akilbekova and Mektepbayeva, 2017; Bella
et al., 2018). To overcome these limitations, in situ bioprinting
emerged to directly print biostructures into the patient’s affected
tissue. In Campbell and Weiss (2007) proposed this concept
for the first time, when they explored inkjet technology to
in situ print fibrinogen, thrombin, and visualization dye into
a rat calvarial defect. The authors stated at that time that they
did not believe this approach could be adopted as a clinical
methodology since it is not a simple off-the-shelf solution
(Campbell and Weiss, 2007). In situ bioprinting has been
adapted to the main bioprinting techniques to directly print
into the defect, namely microextrusion, inkjet printing and
laser-assisted printing (Figure 5). All of these techniques
present different principles, characteristics, advantages, and
disadvantages already described in detail elsewhere (Murphy
and Atala, 2014; Seol et al., 2014; Mandrycky et al., 2016;
Bishop et al., 2017; Peng et al., 2017; Jang et al., 2018). Briefly,
the most common bioprinting technique is microextrusion
(Figure 5A), which consists of a fluid-dispensing system that
uses pneumatic pressure or mechanical forces (piston or screw)
to print a continuous filament through a nozzle (Pati et al.,
2015; Mandrycky et al., 2016; Ozbolat and Hospodiuk, 2016).
Microextrusion allows the bioprinting of high viscosity bioinks
(30 to >6 × 107 mPa/s), a wide selection of biomaterials, and
very high cell densities (Murphy and Atala, 2014; Mandrycky
et al., 2016). Other important advantages are the quality of the
vertical structure and the ability to scale-up 3D structures (Seol
et al., 2014; Mandrycky et al., 2016). The major disadvantages
of this technique are related to low resolution (>100 µm)
and low cell viability (40–80%) (Murphy and Atala, 2014;
Seol et al., 2014).
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FIGURE 5 | Bioprinting Technologies: (A) Microextrusion with pneumatic, plunger or screw-driven dispensing systems; (B) thermal or piezoelectric inkjet printing;
laser-assisted bioprinting technologies: (C) laser guided direct cell printing and (D) laser-induced direct cell printing.
The inkjet printing technique (Figure 5B) is defined as a
non-contact bioprinting technique that generates bioink droplets
(of picolitre volume) that are deposited onto a substrate by a
thermal, piezoelectric, acoustic, or electromagnetic force (Seol
et al., 2014; Zohora and Azim, 2014; Bishop et al., 2017). The
major advantages of this technique are high print speed, high
resolution (20–100 µm), multiple cell/material delivery, low cost,
and good availability (Murphy and Atala, 2014; Mandrycky et al.,
2016; Jang et al., 2018). Nevertheless, this technique presents
some limitations related to poor printing fidelity, material
viscosity (ideally < 10 mPa/s), cell density (< 106 cells/mL),
frequent nozzle clogging, and process scale-up (Seol et al., 2014;
Mandrycky et al., 2016; Bishop et al., 2017).
The laser-assisted bioprinting is an emerging technology
that allows bioprinting cells and hydrogels with micron-scale
resolution (Guillemot et al., 2010). The 3D structure can be
obtained using a laser-guided direct cell printing, in which
the laser traps and guides the cells in the desired direction
(Figure 5C). On the other hand, the laser can induce direct cell
printing in which two layers are needed: the energy-absorbing
layer (containing the ribbon) on the top and a layer on the bottom
containing the bioink (Figure 5D) (Devillard et al., 2014; Murphy
and Atala, 2014; Mandrycky et al., 2016). During the printing
process, the laser pulse is applied to stimulate an area on the
absorbing layer of the ribbon to generate a high-pressure bubble
that forces the bioink toward the collector (Guillemot et al., 2010;
Bishop et al., 2017; Jang et al., 2018). For both approaches, after
deposition, a crosslinking step is needed to maintain the desired
architecture (Mandrycky et al., 2016; Jang et al., 2018). This
bioprinting technique is a nozzle-free printing technique, and
thus is clog-free (Jang et al., 2018). Other important advantages
compared to the other bioprinting techniques are its ability
to print moderately viscous materials (1–300 mPa/s), its high
resolution (microscale), its increased cell viability (>95%), and
its capacity to create multilayered cellular constructs (Murphy
and Atala, 2014; Mandrycky et al., 2016; Jang et al., 2018;
Kérourédan et al., 2018). Its major weaknesses are related to the
side effects of cell exposure to the laser beam (currently not fully
understood), and it being an expensive technique with complex
control (Murphy and Atala, 2014; Mandrycky et al., 2016).
Additionally, stereolithography (SLA) is one of the most
promising bioprinting techniques and uses light (UV, IR, or Vis)
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to photopolymerise a bioink according to a two-dimensional
(2D) pattern, printing a 3D structure layer by layer (Ji and
Guvendiren, 2017; Jang et al., 2018). Contrary to the previous
techniques described, SLA does not dispense bioink. The bioink
is placed into a reservoir with the platform moving in the
z direction after each layer is photopolymerized (Mandrycky
et al., 2016; Bishop et al., 2017). According to the technique
configuration, there is no limitation in terms of bioink viscosity
or structure geometry (Jang et al., 2018). Other important
advantages are the high resolution (microscale) and high cell
viability (>85%) (Mandrycky et al., 2016). However, it presents
prolonged post-processing (Bishop et al., 2017) and is not suitable
for in situ bioprinting due to its intrinsic characteristics, namely
the need of a bioink reservoir.
Since the first approach in 2007, several research groups have
explored in situ bioprinting using two different strategies: one
based on accurate technique development to detect and print
in situ (Cohen et al., 2010; Holzmond and Li, 2017; Li et al.,
2017), and the other consists on in situ bioprinting in animal
models to treat damaged tissues such as cartilage, bone, and skin
(O’Connell et al., 2016; Duchi et al., 2017; Keriquel et al., 2017;
Bella et al., 2018).
Until now, several studies have been conducted to achieve a
proper in situ bioprinting (summarized in the Table 1), exploring
and improving processes and bioinks, and evaluating the induced
regeneration process. In Cohen et al. (2010), published a study
describing for the first time how novel geometric feedback-based
approaches and appropriate printing-material combinations
allow the in situ repair of both chondral and osteochondral
defects. The printing strategy was conducted by CT scanning of
bone before and after creation of the defect to allow the resulting
geometry to be traced back. Feature-based image registration
was conducted to align the printing substrate within the printer
(Cohen et al., 2010).
Ideally, an in situ printing technique should scan the defect,
identify the damaged area, and print new tissue accordingly.
A study developed by Holzmond and Li (2017) presented a
“certify-as-you-build” quality assurance system with the ability
to monitor the printing process, detect the geometry using 3D
digital image correlation (3D-DIC), and compare the printed
geometry with the computer model to identify print errors in situ.
A case study was developed using a fused filament fabrication
(FFF) 3D printer and demonstrating the in situ error detection
of local and global defects (Holzmond and Li, 2017).
Recently, Ding and Chang (2018) developed a novel in situ
bioprinting workflow that integrates imaging of burn wounds
with additive manufacturing to reduce the time of medical
intervention and improving the efficacy of wound healing. The
rapid production of patient-specific skin graft intend to eliminate
the demand for the in vitro fabrication and culture of cell-laden
tissue construct in a laboratory setting (Ding and Chang, 2018).
A study developed by Li et al. (2017) reported the combination
of 3D scanning and 3D printing to treat bone and cartilage
defects. Different defect models were created and in situ 3D
bioprinting feasibility evaluated. High-resolution 3D scans were
used to obtain the 3D digital models (defect and healthy part)
and used Boolean operation to determine the shape of the
defects and to import the target geometries to the 3D bioprinter.
The results suggested that the correlating technology developed
provides a novel methodology to treat open defects in the skeletal
system and can be more effective in non-conventional cases
(Li et al., 2017).
Choong’s team (O’Connell et al., 2016) has been developing
and improving an in situ handheld 3D bioprinting device
(Biopen) for cartilage regeneration (Figure 6). The Biopen allows
simultaneous coaxial deposition of living cells and biomaterials
in a manual, direct−write manner. This device integrates bioink
chambers, a multi-inlet extruder nozzle, a light source, and
a motorized extrusion system (O’Connell et al., 2016; Duchi
et al., 2017; Bella et al., 2018). In vitro experiments were
performed verifying the viability of the cells after processing and
an in vivo study demonstrated an earlier cartilage regeneration
in sheep compared to the performance of bench-based printed
bioscaffolds, microfractures, and the untreated groups (Duchi
et al., 2017; Bella et al., 2018).
Some studies have been developed to achieve bone
regeneration with in situ bioprinting. Keriquel et al. (2010)
presented the first attempt to apply in situ bioprinting
technologies in vivo. They designed a workstation dedicated
to high-throughput biological laser printing and evaluated
their system in a mouse calvarial defect model. Although the
results revealed inconsistent reconstruction of the defects on
test and control sites, the authors demonstrated that is possible
to perform in situ and in vivo bioprinting (Keriquel et al.,
2010). Recently, Keriquel et al. (2017) demonstrated that the
laser-assisted bioprinting technique can be used in mice calvarial
defect model to in situ bioprinting (mesenchymal stromal cells,
collagen and nano-hydroxyapatite) to promote bone tissue
regeneration. Furthermore, the cell bioprinting patterns directly
influence the tissue regeneration (Keriquel et al., 2017).
Skin is the major organ in the human body and has
several important functions (Casey, 2002; Reddy et al., 2013).
Therefore, when damaged at full-thickness, the human life could
be at risk (Yildirimer et al., 2012). Consequently, new and
innovative strategies are required to reduce the time spent in
hospital and to avoid conventional procedures, such as the
use of autografts (Dias et al., 2016). Skardal et al. (2012) used
laser-assisted bioprinting technology to treat full-thickness skin
wounds in nu/nu mice. The study demonstrated that stem cells
obtained from amniotic fluid and bioprinted in a fibrin/collagen
hydrogel carrier are a promising approach for an effective wound
healing therapy in clinical applications (Skardal et al., 2012).
Recently, a hand-held skin bioprinter was developed by Hakimi
et al. (2018), which is a compact extrusion-based approach
that enables the in situ formation of biomaterials and skin
tissue sheets of different architectures and compositions. Bioink
solutions are spatially organized using a microfluidic cartridge
and crosslinked immediately after deposition. According to the
results, the authors demonstrated that the handheld bioprinter
allows the bioprinting of striped, spotted, or fiber arrays sheets,
and single and multilayered biomaterial sheets with different
biopolymers (alginate, fibrin, collagen, and hyaluronic acid)
and cell types (fibroblasts and keratinocytes). The in vitro and
in vivo experiments demonstrated that skin architecture was
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mimicked and that it is possible to cover large wounded areas
(Hakimi et al., 2018).
Recently, Albanna et al. (2019) study described a novel
design and was a proof-of-concept validation of a portable
skin bioprinting system that offers rapid on-site extensive
wounds management (Figure 7). The system has an integrated
imaging technology facilitating the precise delivery of cells
(dermal fibroblasts and epidermal keratinocytes) into the
damaged area. The cartridge-based delivery system used is
similar to the conventional inkjet printing. According to the
in vivo assays, excisional wounds showed rapid wound closure,
reduced contraction and accelerated re-epithelialization when
bioprinted with fibroblasts and keratinocytes in a hydrogel
carrier. Moreover, histological results demonstrated that the new
tissue is similar to healthy skin in terms of dermal structure and
composition (Albanna et al., 2019).
However, this is an emerging field that requires more efforts to
become a clinical reality. At the moment, the major restrictions
are related to: (i) integrated systems that are needed to scan
the damaged area and communicate with the printer to bioprint
according to the defect area, (ii) bioprinting in non-horizontal
surfaces, (iii) printers with high accuracy, (iv) bioinks with the
ability to keep the structure instantly and to promote tissue
regeneration, and (v) to guarantee that the in situ bioprinting
does not affect, interfere with, or damage the surrounding tissues.
Additionally, despite the great potential of bioprinting and
in situ bioprinting, some doubts have been raised regarding
the processing effect on cell integrity and viability. Until
now, few studies have been conducted to further understand
cell/biomolecule damage and cell proliferative ability during and
after printing. The study developed by Nishioka et al. (2004)
described a direct correlation between the compression rate
and peroxidase activity. Higher compression rates correlated
with lower enzyme activity (Nishioka et al., 2004). Recently,
Ning et al. (2018) studied the induced stress on the cells by
bioprinting. Based on this, the team developed a novel method
to characterize and qualify the cell damage caused by both shear
and extensional stresses. The viability and proliferation ability of
cells after bioprinting were investigated and the results illustrated
that the process-induced forces affect not only cell viability but
also their proliferative ability (Ning et al., 2018).
4D in situ Bioprinting
The aforementioned 3D printing emerged to produce complex
structures in several fields based on a layer-by-layer strategy.
More recently, and due to its potential in the biomedical field,
3D bioprinting arose, which enables the production of complex
structures with biological components (Mandrycky et al., 2016).
However, one major limitation remains, since only the initial
state of the printed structure is considered, and the influence
of time and stimuli is ignored (Gao et al., 2016; Momeni
et al., 2017; Morouço and Gil, 2019). Thus, 4D has been
presented as the next generation of tissue regeneration and
intends to mimic not only the organs’ or tissues’ architecture
and properties, but also their dynamic function (Gao et al.,
2016; Momeni et al., 2017). The 4D refers to stimulation and
was described, for the first time, in 2013 by the Massachusetts
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FIGURE 6 | (I) (a) Schematic draw of 3D handheld printer by co-axial extrusion; (b) Representative 3D rendered confocal images of core/shell printed sample labeled
with fluorescent beads (green: gelatin-methacryloyl/hyaluronic acid methacryloyl (GelMa/HAMa) plus 0.1% of lithium-acylphosphinate (LAP); red: GelMa/HAMa),
reproduced with permission from Duchi et al. (2017). (II) (a) Schematic draw of full–thickness chondral defect made. (b) Intraoperative photographs of the Biopen in
action. (c) Defect filled with hand–held in situ 3D printed bioscaffold using the biopen and coated with fibrin glue spray. (d) Macroscopic picture of the retrieved
specimen, reproduced with permission from Bella et al. (2018).
Institute of Technology (MIT) (An et al., 2016; Yang et al., 2019).
4D structures are capable of self-assembly, multi-functionality,
and self-repair, and are time-dependent, printer-independent,
and predictable (Momeni et al., 2017). The concept of 4D
emerged associated with biofabrication and, consequently, with
bioprinting, and can be categorized into two main approaches,
namely materials capable of deformation and structures that
mature after printing (An et al., 2016; Gao et al., 2016).
Materials capable of deformation can also be called responsive
materials that are able to reshape or change their function
according to external stimuli such as water, temperature, pH,
light, and electrical or magnetic fields (Momeni et al., 2017;
Ashammakhi et al., 2018; Betsch et al., 2018; Miri et al., 2018;
Armstrong and Stevens, 2019).
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FIGURE 7 | Skin bioprinter prototype and in situ bioprinting concept. (A) Schematic demonstrating scale, design, and components of the skin bioprinter. (B) The
main components of the system consist of nozzles, driven by up to eight independently dispensing systems connected to a print-head with an XYZ movement
system, in addition to the 3D wound scanner. (C) Skin bioprinting concept. (D) Example of skin bioprinting process, (a) markers were placed around the wound area
used as reference points prior to scanning with a hand-held ZScanner Z700 scanner (b). (c–e) Geometric information obtained. (f) Printing accordingly the geometry.
(E) Depositing of multiple cell types with high precision and control. Layering of fibroblasts (green) and keratinocytes (red) is shown, reproduced with permission from
Albanna et al. (2019).
There are several works exploring the stimuli-responsive
materials in the biomedical field, such as Jamal et al. (2013),
who demonstrated that a bilayered PEG hydrogel construct self-
folded, after immersed in aqueous medium, into cylindrical
structures of different radii with no adverse effect on the
encapsulated cells. In addition, Hendrikson et al. (2017)
described the printing of shape memory polyurethane (Figure 8),
demonstrating that even when cells are seeded onto the scaffolds
in the temporary shape, the permanent shape was recovered,
thus fitting the requirements of a minimally invasive approach.
Moreover, the cells were more elongated after shape recovery,
indicating that a single mechanical stimulus induce changes in
the adherent cells morphology (Hendrikson et al., 2017).
The structures’ maturation after bioprinting, considered as
the second approach, is related to the tissue formation and
maturation (Gao et al., 2016). Despite bioprinting allowing a
precise control over the deposition of cells and/or biomolecules,
the obtained structures cannot promote a complete tissue
formation (An et al., 2016). Consequently, tissue or organ growth
works as an incentive, stimulating the medical device to gradually
break down and be absorbed by the body (An et al., 2016; Gao
et al., 2016). However, scaffold-free strategies induce pattern
changes over time due to the maturation, as a consequence
of cell communication and self-organization (An et al., 2016).
Yu et al. (2016) introduced a novel scalable bioink (scaffold-
free), “tissue strands,” to facilitate the bioprinting of biomimetic
tissues (Figure 9). The generated tissue strands are bioprintable,
can be rapidly fused and maturated by self-assembly, can be
bioprinted in solid form, do not need a liquid delivery medium
during extrusion, and are no scaffold-dependent. According to
the results, this approach can be a novel platform for tissue or
organ biofabrication by taking advantage of the self-assembly
ability of biological tissues, namely for articular cartilage tissue
(Yu et al., 2016).
Until now, and according to An et al. (2016), “4D bioprinting
is still more of a thing-to-be rather than a well-established
matter of fact.” This approach, despite being in an early
stage of development, can contribute significantly to the
biomedical field by producing hierarchical and dynamic tissues.
Moreover, this new generation of structures can be implemented
not only by bioprinting processes, but also through other
technologies. However, several issues remain unclear, such as the
multiresponsive structures, how to achieve precise control over
the deformation, and an in vivo evaluation. Despite the in situ
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FIGURE 8 | Schematic draw showing the working principles behind 4D scaffolds. By exploiting shape memory polymers (SMP), a polyurethane SMP additive
manufactured scaffold is brought to 65◦C where a temporary shape is imparted by applying 50% strain and fixed by cooling at 4◦C. Scaffolds are then cultured at
30◦C to allow cell adhesion and proliferation before restoring the temperature at 37◦C and releasing the strain imparted to the scaffolds through the recovery of the
permanent shape. 4D scaffolds in two different configurations have been tested: 0/90◦ (A) and 0/45◦ (B). Scaffolds were produced with dimensions of
20 mm × 20 mm × 4 mm, reproduced with permission from Hendrikson et al. (2017).
FIGURE 9 | Schematic explaining the concept of tissue printing using tissue strands as a new bioink, reproduced with permission from Yu et al. (2016).
bioprinting advantages and the potential advantages of in situ
4D, this approach has not been explored until now. Nevertheless,
in situ 4D bioprinting will overcome the current limitation of
4D printing related to the adhesion between the structure and
damaged tissue, in addition to achieving in vitro maturation prior
to structure implantation.
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Hybrid in situ Approach
In situ regeneration can revolutionize the future of clinical
procedures, since with this new approach, the human body works
like an “in vivo bioreactor,” providing the ideal environment for
the regeneration of tissues (Wang et al., 2015; Ng et al., 2017).
According to the strategies aforementioned, all technologies
present some advantages and disadvantages in terms of their
material range, accuracy, resolution, and target tissues. However,
over the last few years, in situ bioprinting has gained notoriety
due to the ability to print complex 3D bioengineering structures
layer-by-layer with a high degree of flexibility and reproducibility
(Chua and Yeong, 2014). Similarly to hybrid bioprinting, hybrid
in situ bioprinting, through the combination of different printing
strategies, is an interesting and attractive approach to fabricate
in vivo 3D hierarchical structures combining in the same
structure different scales from nano to macro (Kim et al.,
2008; Xu et al., 2013). In fact, most of the in situ bioprinting
techniques currently under study present the shape of the ECM
analog deposited (droplets or continuous filaments) as their
main difference, which is directly correlated with the type of
material used, its viscosity, and the cell density allowed. Based
on this, and to develop complex structures that mimic the ECM
of the damaged tissue, it will be important to combine micro
techniques, such as the conventional layer-by-layer techniques
(inkjet printing, laser-assisted printing and microextrusion),
with nanotechniques, such as electrospinning. Several studies
have explored the combination of different in vitro bioprinting
techniques and are described elsewhere (Canha-Gouveia et al.,
2015; Dias et al., 2016). Currently, in situ bioprinting studies
have demonstrated the potential of this approach, however, due
to the in vivo conditions, many materials with high mechanical
properties cannot be used as a result of the high temperatures
required to print them. An alternative might be to integrate
in situ spinning or in situ printing techniques, allowing the
production of a complex and hierarchical structure able to mimic
the biomechanical properties of the native ECM.
CONCLUDING REMARKS AND FUTURE
PROSPECTS
Although the many successful in situ TE examples herein
presented, they are not yet fully available to treat patients.
Nevertheless, the existing technological toolbox for constructing
tissue specific ECM analog biomaterials, directly at the defect
site, has opened the possibility for more translational research
in the upcoming years. For this to happen, the portability and
fidelity of the proposed fabrication technologies need to be
even more refined to meet the required simplicity of use in the
surgical room in a relatively short period of time. Each in situ
fabrication technology will have to be optimized to the type of
biomaterial to be used and corresponding functional application.
While in superficial wound lesions different approaches can
be explored with a great degree of success, when looking at
more complex and inaccessible tissues such as bone, cartilage or
cardiovascular tissue, the size and shape of the defects requires
specific biofabrication tools integrating the possibility of mapping
the anatomy of the defect. Time is a very important parameter,
since the prolonged fabrication associated with the scaling-up of
large extensions of tissue might compromise its feasibility in the
surgical room with consequences on cell viability, in case of a cell-
laden approach. Therefore, more automated ways of loading and
ejecting the cell−biomaterial suspensions are required in order to
scale−up the bioconstructs fabrication.
It is also important to realize that complex biofabricated
constructs require a high level of control and monitoring of
biomaterials and, if appropriate, of the processed cells. The
dynamics at the defect site include any physicochemical changes,
such as dimensional stability (shrinking/swelling), degradation,
and pH changes, which might occur in the biomaterials during
the in situ fabrication and the following period. The tissue
regeneration can be followed by assessing functional markers in
real time, for example, by integrating biofabrication technologies
with adequate sensors. As proposed by Holzmond and Li (2017),
the concept of “certify-as-you-build” as a quality assurance
system with the capability to monitor the fabrication process,
should be extended to the post-processing stage to follow the
events of tissue healing and regeneration and to ensure the
expected therapeutic result.
Finally, it is obvious that the clinical application of in situ
biopriting technologies will depend on fruitful collaborations
across different disciplines, covering materials science
and engineering, biochemistry, biology, and medicine, to
foster not only progress in fundamental research but also
translational research.
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